Dengue cases in Ecuador reach 38’607 in 2026, an 11.57% increase over the same period in 2025
Manabí reported 11’137 cases, followed by Guayas with 9134 and Los Ríos with 4347. Together, these provinces accounted for 63.76% of the national total. The highest reported cumulative incidence was in Galápagos, at 2069 cases per 100’000 population, followed by Manabí at 643, Napo at 540, and Santo Domingo de los Tsáchilas at 535.
Reported deaths and the crude case fatality ratio have declined, while ongoing transmission underscores the importance of vector control, timely clinical care, and monitoring for severe disease.
Prevention: Optimal protection against mosquitoes 24/7, including against other mosquito-borne diseases.
Vaccination: The Swiss Committee of Experts in Travel Medicine (ECTM) recommends vaccination with Qdenga® only for travellers over 4 years of age who have already contracted dengue; see the ECTM SOP dengue vaccination available on the PRO version of www.healthytravel.ch.
In case of fever:
The Swiss Expert Committee for Travel Medicine has updated the list of countries with chikungunya transmission risk primarily based on CDC country list and – if available – on epidemiological news (red = changes since the previous update of 10 September 2026).
! Please note: Classifying countries as having an outbreak or an elevated risk is challenging, as definitions vary between sources and data are often lacking or delayed.
0
